EULAR Advocacy Committee
The EULAR Advocacy Committee engages with the EU as well as other national political institutions as a recognised partner and source of expertise in rheumatic and musculoskeletal diseases. The Committee fights for the recognition of the needs of people with rheumatic and musculoskeletal diseases (RMDs) by advocating research and education in rheumatology, promoting the EULAR brand as a reliable source of information, coordinating the work of the Sub-Committee(s) (Communication), and providing strategic guidance on all EULAR messages to internal and external audiences.
Communications Sub-Committee By-Laws
Communications Sub-Committee Regulations
Chair: Prof. Loreto Carmona, Spain
Chair-elect: Prof. Margreet Kloppenburg, Netherlands
Advisor: Prof. Gerd Burmester, Germany & Prof. Annamaria Iagnocco, Italy
Consultant: Rory Douglas Home & Frans Green
Sub-Committee Chair: Anna Voormann, Germany
Committee Members
| Loreto Carmona, Spain Margreet Kloppenburg, Netherlands Gerd Burmester, Germany Annamaria Iagnocco, Italy Anna Voormann, Germany Andri Phoka, Cyprus Sina Bugeja, Malta Fernando Estevez-Lopez, Spain Thea Vliet-Vlieland, Netherlands Xabier Michelena Vegas, Spain Olena Zimba, Poland Jelena Vojinovic, Serbia Philipp Sewerin, Germany Ayhan Dinc, Turkey Razvan Ionescu, Romania Lidia Teixeira, Portugal Zoltan Szekanecz, Hungary Elena Nikiphorou, United Kingdom Ricardo Ferreira, Portugal Oliver Hendricks, Denmark Pia Isomaki, Finland Rikke Moe, Norway Laure Gossec, France |
EULAR Communications Sub-Committee
The Communications Sub-Committee supports EULAR's and the Committee's objective and has the following aims:
- provide strategic advice on EULAR communications, such as the EULAR communication plan, website and other digital communications, PR campaigns, EULAR App and emerging products;
- provide strategic advice on all aspects regarding the official EULAR publications (Annals of the Rheumatic Diseases), such as policies in academic publishing, advertising, applications for Editor of journal, contract with the publisher, ethical policies (e.g. duplicate publication, plagiarism, conflict of interest, etc.).
The Sub-Committee does not pursue gainful or self-help purposes.
Sub-Committee Chair: Anna Voormann, Germany
Sub-Committee Members
Deshire Alpizar, Mexico
Francis Berenbaum, France
Johannes Bijlsma, Netherlands
Nele Caeyers, Belgium
Mrinalini Dey, United Kingdom
Oliver Hendricks, Denmark
Helena Marzo-Ortega, United Kingdom, Spain
Rikke Moe, Norway
Edoardo Prediletto, United Kingdom
Paul Studenic, Austria
Related Information
EULAR Advocacy Newsletter
EULAR is committed to bringing rheumatic and musculoskeletal diseases (RMDs) onto the EU's agenda. Sign up to the EULAR Advocacy newsletter to keep up with the changes that our organisation is working towards in the area of policy and legislation to help achieve better social and economic outcomes for the many millions of people affected by these chronic and debilitating diseases across Europe.
EULAR Project Proposals
All EULAR project proposals are to be submitted by 15 January or 01 July of each year and is subject to the approval of the EULAR Council. The final decision and budget of a project will be determined by the EULAR Council each March and September.
Download the EULAR Project Proposal template
Submit your proposal to:
eular@eular.org
About EULAR Advocacy
EU Advocacy is a key activity for a European umbrella organisation like the European Alliance of Associations for Rheumatology (EULAR).
EULAR Advocacy Partnerships
EULAR is committed to partner with organisations and scientific medical societies at a EU and national level towards improving research funding, social policy legislation and quality of care; assisting advocacy actions on the national and international levels around rheumatic and musculoskeletal diseases (RMDs).
EULAR Advocacy Activities and Materials
In order to persuade governmental and EU key decision-makers supporting the European rheumatology community, EULAR Advocacy develops evidence-based materials about RMDs and communicates its position on key policies and legislation being discussed.
EULAR Policy Statements
As part of its advocacy activities, EULAR produces and adopts a number of documents and declarations that are used to express EULAR’s position and/or demands on different policy issues.
EU Parliament Interest Group on RMDs
The European Parliament Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs) was created in 2009 on the occasion of World Arthritis Day (12 October) and was re-established during the current parliamentary term (2014-2019).
Links to Other Organisations
Partnerships that help to increase the knowledge of the organisations involved and the impact they can have on the political stage.
RMD Definition
EULAR description on Rheumatic and Musculoskeletal Diseases (RMDs)
EULAR Statutes, Reports, and By-Laws
The official statutes of the European Alliance of Associations for Rheumatology, EULAR
EULAR Committees
Established by the Board, Committees are set up to manage and perform the various activities of EULAR on behalf of the Council.